These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15073082)

  • 1. Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugs.
    Duerden M
    BMJ; 2004 Apr; 328(7444):896-7; author reply 897. PubMed ID: 15073082
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary prevention for stroke and transient ischaemic attacks.
    Muir KW
    BMJ; 2004 Feb; 328(7435):297-8. PubMed ID: 14764462
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of a perindopril-based blood-pressure-lowering regimen in patients with previous stroke or transient ischaemic attack (progress). How do the results affect practice in Pakistan?
    Khan M; Kamal AK
    J Pak Med Assoc; 2010 Jul; 60(7):597-8. PubMed ID: 20578620
    [No Abstract]   [Full Text] [Related]  

  • 4. Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice.
    Jackson G
    Int J Clin Pract; 2003 Jun; 57(5):385-7. PubMed ID: 12846342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
    Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
    Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

  • 7. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial.
    Keenan K; Hayen A; Neal BC; Irwig L
    BMJ; 2009 Apr; 338():b1492. PubMed ID: 19406886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension and prevention of ischemic stroke.
    Aronow WS; Frishman WH
    Curr Cardiol Rep; 2004 Mar; 6(2):124-9. PubMed ID: 14759357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
    Schiffrin EL
    Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary prevention of stroke.
    MacDougall NJ; Amarasinghe S; Muir KW
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1103-15. PubMed ID: 19764863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global impact of stroke.
    Chalmers J
    Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of ischemic stroke--Part 1].
    Hamann GF; Liebetrau M
    Fortschr Neurol Psychiatr; 2012 Nov; 80(11):654-68; quiz 668-70. PubMed ID: 23139067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
    Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
    Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of arterial hypertension in stroke prevention].
    Britov AN; Bystrova MM; Orlov AA
    Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in reducing the burden of stroke.
    Chalmers J; Chapman N
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1091-5. PubMed ID: 11903323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
    Matsumoto M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary prevention for stroke and transient ischaemic attacks: Horizons needs expanding.
    Ray S; Doney AS; MacWalter RS
    BMJ; 2004 Apr; 328(7444):896; author reply 897. PubMed ID: 15073081
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
    Schiffrin EL
    Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.